SCMP Share Price |
||||
| Open | 10.35 | Change | Price | % |
| High | 11.35 | 1 Day | 0.80 | 7.80 |
| Low | 10.32 | 1 Week | 0.55 | 5.24 |
| Close | 11.05 | 1 Month | 0.10 | 0.91 |
| Volume | 1794949 | 1 Year | -0.44 | -3.83 |
| 52 Week High 17.55 | ||||
| 52 Week Low 9.30 | ||||
| SCMP Important Levels | |
| Resistance 2 | 12.00 |
| Resistance 1 | 11.61 |
| Pivot | 10.91 |
| Support 1 | 10.49 |
| Support 2 | 10.10 |
| NASDAQ USA Most Active Stocks | |||
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| FNFG | 10.18 | -0.20% | |
| DCTH | 0.13 | -13.33% | |
| DELL | 13.86 | 0.22% | |
| RFMD | 16.59 | -2.07% | |
| RIMM | 13.03 | 0.39% | |
| BBEP | 0.12 | 0.00% | |
| GTAT | 0.44 | 0.00% | |
| NASDAQ USA Top Gainers Stocks | |||
| ARCI | 1.45 | 137.70% | |
| FALC | 0.40 | 60.00% | |
| AMCF | 0.03 | 50.00% | |
| LOCM | 0.09 | 50.00% | |
| OPXAW | 0.10 | 42.86% | |
| VRTA | 4.50 | 38.46% | |
| BSDM | 0.62 | 26.53% | |
| SNTA | 0.34 | 25.93% | |
| OTT | 2.39 | 25.13% | |
| ATRM | 1.70 | 21.43% | |
| NASDAQ USA Top Losers Stocks | |||
| TXCC | 0.01 | -95.00% | |
| HCIIP | 10.10 | -67.52% | |
| CRMB | 0.27 | -57.81% | |
| KIOR | 0.03 | -57.14% | |
| PTSX | 0.05 | -50.00% | |
| OSH | 0.26 | -49.02% | |
| OSH | 0.26 | -49.02% | |
| DVOX | 0.05 | -44.44% | |
| PRXI | 0.21 | -43.24% | |
| TRGT | 0.96 | -41.46% | |
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP)
| SCMP Technical Analysis | 2 |
| As on 21st Aug 2017 SCMP Share Price closed @ 11.05 and we RECOMMEND Sell for LONG-TERM with Stoploss of 11.78 & Strong Buy for SHORT-TERM with Stoploss of 10.48 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| SCMP Target for August | |
| 1st Target up-side | 11.26 |
| 2nd Target up-side | 11.55 |
| 3rd Target up-side | 11.83 |
| 1st Target down-side | 10.44 |
| 2nd Target down-side | 10.15 |
| 3rd Target down-side | 9.87 |
Sucampo Pharmaceuticals, Inc. ( NASDAQ USA Symbol : SCMP ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
ABAX
46.54 0.01 (0.02 %) LT : Strong Sell ST : Strong Sell |
ABIO
1.15 -0.12 (-9.45 %) LT : Strong Sell ST : Strong Sell |
ABMD
153.32 1.18 (0.78 %) LT : Strong Buy ST : Strong Buy |
ACAD
30.94 -0.14 (-0.45 %) LT : Buy ST : Buy |
ACHC
47.66 0.76 (1.62 %) LT : Buy ST : Sell |
|
|
|
||||||||||||||||||||||
|
Interactive Technical Analysis Chart Sucampo Pharmaceuticals, Inc. ( SCMP NASDAQ USA )
Your Comments and Response on Sucampo Pharmaceuticals, Inc.
SCMP Business Profile
Sucampo Pharmaceuticals, Inc. is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company�s prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company�s products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl). AMITIZA is marketed in the United States for three gastrointestinal indications: chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.